Not Losing Weight on Mounjaro: What's Actually Going On

Is this a timing problem, or something else?

The first question worth asking honestly is how long you've been on your current dose. Tirzepatide's appetite-suppressing effect builds over weeks, not days, and the 2.5mg starting pen is specifically designed as a tolerability phase, your body adjusting, not the medicine doing its main job. Prescribers typically hold patients at each strength for around four weeks before increasing, and most of the meaningful weight response in clinical trials came at 7.5mg and above.

If you've been on Mounjaro and not losing weight for six or more weeks at a stable dose, that's a more useful signal. It's worth checking how long Mounjaro typically takes to work for a realistic timeline based on trial data. The honest acknowledgement here is that waiting when you've already waited a long time feels unreasonable, and that frustration is fair. But acting too soon (switching medicines, stopping, or self-adjusting doses) often resets progress that was quietly building.

A note on expectations: even in the SURMOUNT-1 trial, which is cited by NICE in their tirzepatide guidance, weight loss was a gradual curve across 72 weeks. The people who lost the most weren't the ones who lost it fastest.

What tends to blunt Mounjaro's effect in real life

Several factors can work against tirzepatide's appetite and metabolic effects, and most of them are addressable once identified. Calorie intake is the most common. Mounjaro reduces hunger significantly in most people, but if ultra-processed foods, alcohol, or liquid calories still feature heavily, the deficit the medicine creates can be partially cancelled out. The medicine changes appetite signals; it doesn't override every dietary habit automatically.

Certain medications can counteract weight loss even on a GLP-1. Antidepressants (particularly some SSRIs and tricyclics), antipsychotics, corticosteroids and some contraceptive formulations are associated with weight gain or weight-loss resistance. This is worth discussing with your prescriber rather than stopping any medication, the answer is usually a clinical conversation, not a unilateral change.

Thyroid function matters too. Undiagnosed or undertreated hypothyroidism lowers metabolic rate and can stall weight loss regardless of what you're taking. If you haven't had thyroid function checked recently, it's a reasonable thing to flag. Sleep is another factor that's easy to dismiss: poor sleep raises ghrelin (the hormone that drives hunger) and lowers leptin, which directly fights against what tirzepatide is trying to do. For a broader picture of what affects weight beyond the medicine itself, our weight-loss treatment overview covers the lifestyle context that works alongside GLP-1 treatment.

When to raise it with your prescriber

If you're genuinely on Mounjaro and not losing weight after eight to twelve weeks at a consistent dose, with no obvious dietary or lifestyle explanation, it's time for a clinical conversation. Your prescriber should review: whether a dose increase is appropriate, whether any concurrent medication is interfering, and whether there are any investigations worth arranging. They may also want to confirm your weight at the point of assessment, which is why the detailed evidence-checking that happens at dose-review stage matters.

There's a separate consideration if you've recently transferred from another provider or started at a higher dose elsewhere. Evidence of your current treatment is something prescribers should check before continuing or escalating, that's part of safe practice, not bureaucracy. If your situation is more specific, our team has covered similar scenarios in detail for people who are already on Mounjaro without seeing results and those who feel stuck on their current dose.

One thing that's worth saying plainly: if Mounjaro is genuinely not working for you after a proper trial at adequate doses, semaglutide (Wegovy) is the other licensed option, and some people respond better to one than the other. That's a clinical decision, not a self-service switch. For context on what private treatment involves from a cost and service perspective, the Mounjaro pricing guide explains what a legitimate, clinically-supervised prescription includes. The wider Mounjaro treatment page covers the full picture of how tirzepatide works and what to expect across the dose schedule.

What a prescriber can actually do about it

A prescriber reviewing a plateau has a few levers to pull. Dose titration is the most straightforward, if you've been at 5mg for four weeks with no progress and no significant side effects, moving to 7.5mg is the standard next step. If you're wondering why the scales haven't moved despite injecting on schedule, our guide to being on Mounjaro and not losing weight walks through the most common clinical and lifestyle reasons in detail. The clinical evidence, summarised in the NHS tirzepatide medicines page, shows the dose-response relationship is real: higher doses produce greater appetite suppression and greater average weight loss.

Beyond titration, a prescriber might suggest structured dietary changes alongside treatment (adequate protein, reduced ultra-processed food, consistent meal timing) or flag whether it's worth investigating thyroid function or reviewing any concurrent medications. If there's a specific barrier (disrupted sleep from sleep apnoea, for instance, which is itself a weight-related condition), treating that condition can unlock progress that the medicine alone couldn't achieve.

What a prescriber cannot do is guarantee a specific outcome. Biology varies. Some people respond more than others at the same dose, and the reasons aren't always identifiable. What they can do is rule out avoidable causes and optimise the plan. If you'd like a clinical review of where you are, you can speak to our prescribers through a free consultation, reviewed the same day by a real clinician, not a triage algorithm.